DRACP01831 |
PIER4 (Tat-PIER1) |
GRKKRRQRRRPQ |
12 |
Free |
DRACP01832 |
IL4RPep1KLA |
CRKRLDRCGGGKLAKLAKKLAKLAK |
25 |
Free |
DRACP01833 |
RPS6 subunit anticancer peptide |
ISGGNDKQGFPM |
12 |
Free |
DRACP01834 |
ANS-1 |
AVPSP |
5 |
Free |
DRACP01835 |
ANS-2 |
AVPSPPPAS |
9 |
Free |
DRACP01836 |
FGF2 derived peptides |
KRTGQYKLGSKT |
12 |
Free |
DRACP01837 |
API5 derived peptides |
LEDVTGEEF |
9 |
Free |
DRACP01838 |
Varv Hm |
GLPVCGETCFGGTCNTPGCSCXTWPVCSRN |
30 |
Free |
DRACP01839 |
Varv He |
GLPVCGETCFGGTCNTPGCSCXTWPVCSRN |
30 |
Free |
DRACP01840 |
vitri B |
GYPICGESCVGGTCNTPGCSCSWPVCTTN |
29 |
Free |
DRACP01841 |
vitri C |
GLPICGETCVGGTCNTPGCFCTWPVCTRN |
29 |
Free |
DRACP01842 |
vitri D |
GLPVCGETCFTGSCYTPGCSCNWPVCNRN |
29 |
Free |
DRACP01843 |
vitri E |
GLPVCGETCVGGTCNTPGCSCSWPVCFRN |
29 |
Free |
DRACP01844 |
vitri F |
GTLPCGESCVWIPCISSVVGCACKSKVCYKD |
31 |
Free |
DRACP01845 |
vitri A |
GIPCGESCVWIPCITSAIGCSCKSKVCYRN |
30 |
Free |
DRACP01846 |
CP-EPS8-NLS |
GRKKRRQRRRPQSKRKKNKKGKRK |
24 |
Amidation |
DRACP01847 |
MIA-602 |
YADAIFTNSYRKVLGQLSARKLLQDIMSR |
29 |
Amidation |
DRACP01848 |
MIA-606 |
YADAIFTXSYRKVLGQLSARKLLQDIMSR |
29 |
Free |
DRACP01849 |
MIA-690 |
YADAIFTNSYRKVLGQLSARKLLQDIMSR |
29 |
Amidation |
DRACP01850 |
JMR-132 |
YADAIFTAXXHKVLGQLSAHKLLQDIMSR |
29 |
Free |
DRACP01851 |
Amurin-2a |
FLPLLLAGLPSFLCLVFKKC |
20 |
Free |
DRACP01852 |
Amurin-2a [L4K] |
FLPKLLAGLPSFLCLVFKKC |
20 |
Free |
DRACP01853 |
Amurin-2a [S11K] |
FLPLLLAGLPKFLCLVFKKC |
20 |
Free |
DRACP01854 |
K(RW)3 |
KRWRWRW |
7 |
Free |
DRACP01855 |
Desotamide B [V2I] |
NIlLWG |
6 |
Free |
DRACP01856 |
Wollamide B [D-Orn6Orn] |
NVlLWX |
6 |
Free |
DRACP01857 |
Desotamide A |
NGWLLI |
6 |
Free |
DRACP01858 |
Desotamide C |
XGNIlL |
6 |
Free |
DRACP01859 |
Desotamide D |
XGNIlL |
6 |
Free |
DRACP01860 |
KFAK(1) |
KFAK |
4 |
Free |